ARCHIVES

MET Inhibitor Improved Time To Progression by 56 Percent

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Obituary: Ronald Herberman, 72, UPCI Founding Director

July 3, 2013

Turmoil in Texas: SEC Issues Subpoena to AVEO on Tivozanib

July 12, 2013

Consensus Conference In Early Breast Cancer Planned For June

May 11, 1990

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

April 27, 2001

Alternating Mammography, MRI Tested For High-Risk Women

January 30, 2009

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010